Indications and uses
First aid to help prevent infection in, minor cuts, scrapes and burns.
First aid to help prevent infection in, minor cuts, scrapes and burns.
Clean the affected area Apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily May be covered with a sterile bandage
Drug Facts
Bacitracin Zinc 400 units
Neomycin sulfate 5 mg (equivalent to 3.5 mg of neomycin base)
Polymyxin B Sulfate 5000 units
First Aid Antibiotics
First aid to help prevent infection in, minor cuts, scrapes and burns.
For external use only
If ingested, get medical help or contact a poison control center right away.
Petrolatum
1-800-234-1464
mooremedical
Supporting Health & Care
Reorder No. 82466
UPN# 0-0607415-82466-7
MooreBrand®
Triple Antibiotic
Ointment
144 Packets
Each Packet Net. Wt. 1.0gm
First aid to help prevent infection
associated with minor cuts, scrapes
and burns.
To Reorder:
Call: 1.800.234.1464
Fax: 1.800.944.6667
Online:
www.mooremedical.com
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| bacitracin zinc | ACTIVE INGREDIENT | 89Y4M234ES | 2 | |
| neomycin sulfate | ACTIVE INGREDIENT | 057Y626693 | 2 | |
| polymyxin b sulfate | ACTIVE INGREDIENT | 19371312D4 | 2 | |
| bacitracin | ACTIVE MOIETY | 58H6RWO52I | 2 | |
| neomycin | ACTIVE MOIETY | I16QD7X297 | 2 | |
| polymyxin b | ACTIVE MOIETY | J2VZ07J96K | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55670-600 | 55670-600-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PETROLATUM | 4T6H12BN9U | IACT |
| BACITRACIN ZINC | 89Y4M234ES | ACTIM |
| NEOMYCIN SULFATE | 057Y626693 | ACTIM |
| POLYMYXIN B SULFATE | 19371312D4 | ACTIM |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ce2929d2-67f1-0e67-e053-2a95a90a1aa5 | 3df00499-a6eb-4ca5-8119-d455df2aab53 | 2021-10-12 | Warnings | ce2929d2-67f1-0e67-e053-2a95a90a1aa5 3df00499-a6eb-4ca5-8119-d455df2aab53 |
Adverse event summaries are temporarily unavailable. Other product information remains available.